Compass Therapeutics (CMPX)'s 30-day implied volatility (IV30) was 95.0% at the close on November 6, 2026, up from 67.0% the day before, against a 52-week range of 50.7% to 335.4%. Its 20-day historical volatility was 78.6%.
Data as of November 6, 2026.